Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial
J Thorac Dis
.
2018 Feb;10(2):695-698.
doi: 10.21037/jtd.2018.01.119.
Authors
Peter L Thompson
1
,
S Mark Nidorf
1
Affiliation
1
Heart Research Institute, Harry Perkins Institute of Medical Research, University of Western Australia and Genesis HeartCare Western Australia, Perth, Australia.
PMID:
29607136
PMCID:
PMC5864670
DOI:
10.21037/jtd.2018.01.119
No abstract available
Publication types
Editorial
Comment